Related Experiment Video
Updated: Jan 9, 2026
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Impact of low-FODMAP diet on symptom relief in irritable bowel syndrome patients
Yifeng Luo1, Zhijuan Xu2, Rui Li3
1Department of gastroenterology, Community Health Service Center in Zhuantang Street, Hangzhou, China.
Background And Objectives:
Irritable bowel syndrome (IBS) stands as a prevalent functional gastrointestinal condition known for causing persistent abdominal pain, changes in bowel patterns, and diminished quality of life. The low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet has emerged as a potential approach to managing IBS through dietary adjustments. To explore how the low FODMAP diet affects symptom relief, nutritional well-being, and overall quality of life in IBS patients when compared to those adhering to a standard diet.
Methods And Study Design:
A retrospective cohort study was conducted, including patients with IBS categorized into a regular diet group and a low FODMAP diet group. Dietary intake, daily nutrient intake, IBS symptom severity, adverse events, and quality of life were assessed.
Results:
The low FODMAP diet group demonstrated significantly lower intake of fermentable carbohydrates, including total dietary fiber, fructose, lactose, sorbitol, and total carbohydrates, compared to the regular diet group. Additionally, the low FODMAP diet group exhibited favourable nutritional profiles, reflecting higher intake and utilization of essential nutrients such as vitamin C, iron, calcium, vitamin D, and omega-3 fatty acids. Moreover, significant improvements in symptom severity, adverse event profiles, and quality-of-life scores were observed in the low FODMAP diet group compared to the regular diet group.
Conclusions:
The Low-FODMAP Diet significantly alters nutrient intake in IBS patients, which may contribute to the observed symptom relief.
More Related Videos
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: